GSK plc -Getting Ahead of Respiratory Diseases Transcript
Hello, everyone. Welcome to our Getting ahead of Respiratory Diseases event with GSK management. As usual, the presentation was e-mailed to our distribution list earlier today and is available on gsk.com. Please turn to Slide 2. This is the usual cautionary and forward-looking statements. Please turn to Slide 3. Today's speakers are our Chief Scientific Officer, Tony Wood; and Chief Commercial Officer, Luke Miels. And our presentation will last approximately 30 minutes a day followed by 30 minutes for Q&A. Turning to Slide 4. I will now hand the call over to Tony.
Hi, everyone, and welcome to our Respiratory Meet the Management event. As you know, GSK prevents and treats disease in 4 therapy areas. Most recently, we spoke to you about HIV. Today, we'll focus on respiratory, where we have assets across vaccines, specialty and general medicines product areas.
Please turn to the next slide. In this deep dive, we'll cover the following areas: firstly, our expertise in
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
